about
Ocular parasitoses: A comprehensive review.Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan.Trends in the Screening and Treatment of Retinopathy of Prematurity.The limited role of NH2-terminal c-Jun phosphorylation in neuronal apoptosis: identification of the nuclear pore complex as a potential target of the JNK pathway.Retinal cell death and current strategies in retinal neuroprotection.Pharmacotherapies for Retinal Detachment.Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis.NOVEL CLASSIFICATION SYSTEM FOR COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM.Hypertensive emergency presenting as blurry vision in a patient with hypertensive chorioretinopathy.Evaluation of Screening for Retinopathy of Prematurity by ROPtool or a Lay Reader.Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.Bilateral BRVO in a patient with recurrent prostate cancer.Immunogammopathy maculopathy associated with Waldenström macroglobulinemia is refractory to conventional interventions for macular edema.PERIPHERAL RETINAL VASCULOPATHY IN COCKAYNE SYNDROME.Photoreceptor metabolic reprogramming provides survival advantage in acute stress while causing chronic degeneration.Structure-Guided Design and Initial Studies of a Bifunctional MEK/PI3K Inhibitor (ST-168).Ethics of Placebo Procedures in Ophthalmic Surgical Trials.Growth Kinetics in Layer-by-Layer Assemblies of Organic Nanoparticles and Polyelectrolytes.Intraocular tooth.Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion.Choroidal neovascular membrane in paediatric patients: clinical characteristics and outcomes.Screening for vision-threatening diabetic retinopathy in South India: comparing portable non-mydriatic and standard fundus cameras and clinical exam.Combined vitrectomy and glaucoma drainage device implantation surgical approach for complex pediatric glaucomas.Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.Retinal Neuroprotection: Overcoming the Translational Roadblocks.Macular hole closure following spontaneous release of vitreomacular traction.Predictors of Photographic Quality with a Handheld Nonmydriatic Fundus Camera Used for Screening of Vision-Threatening Diabetic Retinopathy.SELF-PEELING EPIRETINAL MEMBRANE.Vision Loss After Central Retinal Artery Occlusion Secondary to Orbital Sarcoid Mass.Posterior Polar Annular Choroidal Dystrophy.Arterial macroaneurysm of the optic disc.Recovery of outer retina in acute idiopathic blind spot enlargement (AIBSE).Vitreous Cytokine Expression and a Murine Model Suggest a Key Role of Microglia in the Inflammatory Response to Retinal Detachment.Smartphone-Based, Rapid, Wide-Field Fundus Photography for Diagnosis of Pediatric Retinal Diseases.Serous retinal detachment in hypertensive posterior reversible encephalopathy syndromeRe: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9)Retinal flecks in primary hyperoxaluriaCTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotypeDiagnostic and Therapeutic ChallengesOcular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors
P50
Q30244721-53A1B0AA-EE54-4F17-B7EB-1644AECBAD2AQ34257625-59E957A3-2E1C-4D43-8692-74EA5F04D639Q36224167-5FD8A74B-FEEE-4133-A444-599C0CE5B862Q36320929-1E34B652-EAE7-4836-AFD6-0B64CC0F847BQ38194848-24C611FC-E755-4574-A3C6-942A300D0FEDQ38796890-76C81D1A-AE94-48B8-BCCC-B2AC526322B2Q38977106-413E5C85-5410-4CBA-A5C1-443BAE78E9D5Q39093538-331C95E9-E58B-427F-8CA3-DC43D7FB8EB2Q39953249-79C39506-3C69-4C7D-9A50-204635B2076BQ41038865-711803EB-CD5F-4F1C-A8A6-047BE8B41757Q41891788-83417263-76C1-45F1-8FA6-415388CA3169Q43202337-74CE73C6-5E05-4C90-9134-FAE54595653AQ43467102-D7CCF43A-A8B0-4F03-8EB4-62A57CF80206Q45947814-DAECB802-A8AA-4FFF-ABE1-E0AFA4C41ACEQ47098007-ED1F20A7-6C17-4A82-BE1E-68E0A3119D8CQ47760790-25238F3C-6901-4207-BC2F-8CED73F4BF8FQ47892903-CCD0E918-E1BD-48AA-BB75-F0DBDBEBB0C0Q48214899-AB5D6DD3-C622-4AED-BB79-0E4C3B30677EQ48517184-688EFB3F-FC28-49B7-8F85-110DFA4790CEQ49981383-11CAA610-26E8-49E3-BE8D-3703022857B7Q50021634-106A15E0-B2EE-4595-9537-AD2350CCD9C2Q50081277-4A49B438-3086-494B-BC09-0D25CE45F958Q50981695-4C750A5B-CC4C-462F-AFA3-D1AA0CF0F2EDQ52312509-FF1BA9A4-FF90-47C7-B5C3-F1840FFAA2DDQ52558852-F3245B0D-B4C5-4EB1-B699-4589063E4349Q52679402-11ED0535-3030-4CF7-8D7B-8DBF577FC14BQ52938566-07237D03-279D-4CE0-94DE-17076FC5FE01Q52958951-25B7FF4E-AD4A-4251-A7CF-17E0E518B48AQ53058620-E7DE12E0-1CAB-4829-B416-5C50CAD6355CQ53247003-F3060C95-E354-4738-94BB-B632A0E35F61Q55357459-F9A2FDC2-0ED0-44E9-8F0E-DBC5AE5F7D53Q55417413-43A0147C-7479-43F1-9D8A-C87D9EEF46B3Q64948475-1ED4BCC5-6DF0-4334-AE51-38667367CE3CQ64989332-B6074E67-6D77-44ED-9EEE-5224812DAF7FQ83584224-A8383E88-0F27-4E00-BC3B-3CC0368F5730Q85650479-CF4CC473-1FB7-482D-8DE6-6BF4F6549A59Q86420011-241A7254-A398-4113-83B2-8C5C4BEA0CDFQ87443230-C7230F0A-4C5E-437D-99A0-F01A47330026Q87586581-5C3AAEFC-4F78-4DA8-8A07-E65E6767CF12Q88512529-F7B519D2-C650-4E03-8545-640B50355635
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Cagri G Besirli
@en
Cagri G Besirli
@nl
type
label
Cagri G Besirli
@en
Cagri G Besirli
@nl
prefLabel
Cagri G Besirli
@en
Cagri G Besirli
@nl
P31
P496
0000-0001-7154-2024